{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:47:51Z","timestamp":1790426871071,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Avant Mutual Group Ltd."},{"DOI":"10.13039\/501100001168","name":"Cancer Council Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001168","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.urology.2016.12.011","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T02:15:28Z","timestamp":1482113728000},"page":"11-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"special_numbering":"C","title":["Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-7402","authenticated-orcid":false,"given":"Matthew J.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-0613","authenticated-orcid":false,"given":"Harrison Y.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4574-5738","authenticated-orcid":false,"given":"Michael","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4382-8169","authenticated-orcid":false,"given":"Jeremy","family":"Grummet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian M.E.","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2016.12.011_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","article-title":"Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study","volume":"63","author":"Wagenlehner","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.juro.2015.07.099","article-title":"Prostate needle biopsy outcomes in the era of the U.S. preventive services task force recommendation against prostate specific antigen based screening","volume":"195","author":"Banerji","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0020","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrurol.2013.322","article-title":"Reducing infection rates after prostate biopsy","volume":"11","author":"Wagenlehner","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S1473-3099(15)00270-4","article-title":"Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study","volume":"15","author":"Teillant","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0035","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1017\/S0950268815002885","article-title":"The global burden of major infectious complications following prostate biopsy","volume":"144","author":"Bennett","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.urology.2016.12.011_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cid\/cit193","article-title":"Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli","volume":"57","author":"Williamson","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.urology.2016.12.011_bib0045","article-title":"Antibiotic prophylaxis for transrectal prostate biopsy","author":"Zani","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2016.12.011_bib0050","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","article-title":"Best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0055","article-title":"Perioperative antibacterial prophylaxis in urology","volume":"Vol. 2013","author":"Grabe","year":"2011"},{"key":"10.1016\/j.urology.2016.12.011_bib0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1179\/1973947815Y.0000000001","article-title":"The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients","volume":"28","author":"Kandemir","year":"2016","journal-title":"J Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0090-4295(98)00313-6","article-title":"Variability in patient preparation for prostate biopsy among American urologists","volume":"52","author":"Shandera","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0974-7796.152017","article-title":"Current practice of prostate biopsy in Australia and New Zealand: a survey","volume":"7","author":"Davis","year":"2015","journal-title":"Urol Ann"},{"key":"10.1016\/j.urology.2016.12.011_bib0075","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0080","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.eururo.2011.12.058","article-title":"Infectious complications and hospital admissions after prostate biopsy in a European randomized trial","volume":"61","author":"Loeb","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0085","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0090","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?","volume":"62","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0095","article-title":"Complications after systematic, random, and image-guided prostate biopsy","author":"Borghesi","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dks401","article-title":"The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention","volume":"68","author":"Batura","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0105","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/jac\/dks401","article-title":"The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention\u2014authors' response","volume":"68","author":"Batura","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5694\/mja12.11719","article-title":"Multifocal abscesses due to multiresistant Escherichia coli after transrectal ultrasound-guided prostate biopsy","volume":"198","author":"Roberts","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.urology.2016.12.011_bib0115","author":"US Food and Drug Administration"},{"key":"10.1016\/j.urology.2016.12.011_bib0120","unstructured":"Liss M.A., Ehdaie B., Loeb S., et\u00a0al. AUA White Paper on The Prevention and Treatment of the More Common Complications Related to Prostate Biopsy Update, Vol. 2016. American Urological Association (AUA), Education and Research, Inc.; 2016."},{"key":"10.1016\/j.urology.2016.12.011_bib0125","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.urology.2016.12.011_bib0130","series-title":"Guidelines. Methodology section","year":"2015"},{"key":"10.1016\/j.urology.2016.12.011_bib0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11255-013-0529-5","article-title":"Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: need for additional infection prevention strategies?","volume":"46","author":"Gopal Rao","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2016.12.011_bib0140","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.juro.2013.12.026","article-title":"Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative","volume":"191","author":"Womble","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0145","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s11255-012-0145-9","article-title":"Bacterial sepsis following prostatic biopsy","volume":"44","author":"Carmignani","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2016.12.011_bib0150","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","article-title":"Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy","volume":"185","author":"Liss","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.urology.2010.12.067","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment","volume":"77","author":"Zaytoun","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0160","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.juro.2012.10.005","article-title":"Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare","volume":"189","author":"Loeb","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/iju.12207","article-title":"Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study","volume":"21","author":"Campeggi","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0170","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.juro.2014.04.098","article-title":"Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy","volume":"192","author":"Lundstrom","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0175","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s12879-015-1328-7","article-title":"Risk factors for infection following prostate biopsy\u2014a case control study","volume":"15","author":"Anderson","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0185","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/cid\/cis194","article-title":"Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen","volume":"54","author":"Williamson","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0190","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/cid\/ciu1129","article-title":"Clinical and microbiological determinants of infection after transrectal prostate biopsy","volume":"60","author":"Liss","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0195","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2014.01.008","article-title":"Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis","volume":"43","author":"Roberts","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.urology.2016.12.011_bib0200","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1469-0691.2011.03638.x","article-title":"Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy\u2013should we reassess our practices for antibiotic prophylaxis?","volume":"18","author":"Steensels","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.urology.2016.12.011_bib0205","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.juro.2014.06.005","article-title":"Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy","volume":"192","author":"Liss","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0210","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1464-410X.2011.10561.x","article-title":"Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use","volume":"109","author":"Patel","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/cir273","article-title":"Country-to-country transfer of patients and the risk of multi-resistant bacterial infection","volume":"53","author":"Rogers","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0220","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1111\/j.1464-410X.2012.11001.x","article-title":"Travel-associated extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infection following transrectal ultrasound-guided prostate biopsy","volume":"109","author":"Williamson","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0924-8579(00)00182-5","article-title":"Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology","volume":"15","author":"Wagenlehner","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.urology.2016.12.011_bib0230","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/iju.12454","article-title":"Prevalence of antimicrobial resistance in normal rectal flora of patients undergoing transrectal ultrasonography-guided prostate biopsy in Korea","volume":"21","author":"Lee","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000335506","article-title":"Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand","volume":"88","author":"Siriboon","year":"2012","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0240","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.juro.2014.07.086","article-title":"Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy","volume":"193","author":"Bruyere","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0245","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1464-410X.2012.11637.x","article-title":"Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy","volume":"111","author":"Taylor","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.urology.2011.02.065","article-title":"Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms","volume":"78","author":"Akduman","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0255","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dki344","article-title":"Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey","volume":"56","author":"Arslan","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/669512","article-title":"Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate","volume":"34","author":"Dumford","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.urology.2016.12.011_bib0180","first-page":"5135","article-title":"Multi-drug resistant E. coli urosepsis in physicians following transrectal ultrasound guided prostate biopsies\u2013three cases including one death","volume":"17","author":"Carlson","year":"2010","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urology.2008.01.065","article-title":"Multi-drug-resistant bacteremia after transrectal ultrasound guided prostate biopsies in hospital employees and their relatives","volume":"72","author":"Kamdar","year":"2008","journal-title":"Urology"},{"issue":"suppl 2","key":"10.1016\/j.urology.2016.12.011_bib0270","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/bju.12590","article-title":"Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate","volume":"113","author":"Losco","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0275","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2006.05.003","article-title":"Single-dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors","volume":"50","author":"Lindstedt","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0280","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000296290","article-title":"Is it possible to predict sepsis, the most serious complication in prostate biopsy?","volume":"84","author":"Simsir","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0285","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/iju.12634","article-title":"Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England","volume":"22","author":"Anastasiadis","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.urology.2014.10.047","article-title":"Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies","volume":"85","author":"Luong","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0295","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11255-014-0904-x","article-title":"Does metabolic syndrome increase the risk of infective complications after prostate biopsy? A critical evaluation","volume":"47","author":"Sahin","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2016.12.011_bib0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.urology.2014.07.078","article-title":"Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum beta-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy","volume":"85","author":"Tsu","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0305","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1086\/671734","article-title":"Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy","volume":"34","author":"Suwantarat","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.urology.2016.12.011_bib0310","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/bju.13023","article-title":"Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging\/ultrasound-fusion biopsy for the diagnosis of prostate cancer","volume":"116","author":"Borkowetz","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0315","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.juro.2012.05.006","article-title":"Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy","volume":"188","author":"Hossack","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0320","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.13031","article-title":"Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience","volume":"116","author":"Ong","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0325","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bju.12860","article-title":"Transperineal prostate biopsy: template-guided or freehand?","volume":"115","author":"Dundee","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0330","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bju.12536","article-title":"Sepsis and \u201csuperbugs\u201d: should we favour the transperineal over the transrectal approach for prostate biopsy?","volume":"114","author":"Grummet","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0335","volume":"Vol. 2014","author":"Grabe","year":"2014"},{"key":"10.1016\/j.urology.2016.12.011_bib0340","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10147-015-0831-6","article-title":"Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse events","volume":"20","author":"Namekawa","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.urology.2016.12.011_bib0345","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/bju.13024","article-title":"Transperineal template-guided prostate biopsy: 10 years of experience","volume":"117","author":"Mai","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0350","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.urology.2013.02.019","article-title":"Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores","volume":"81","author":"Pepe","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0355","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eururo.2014.03.002","article-title":"Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies","volume":"66","author":"Pokorny","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0360","first-page":"326","article-title":"The current and future role of magnetic resonance imaging in prostate cancer detection and management","volume":"4","author":"Radtke","year":"2015","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0365","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0022-5347(05)00957-2","article-title":"Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review","volume":"175","author":"Eichler","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0370","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1097\/01.ju.0000116449.01186.f7","article-title":"Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores","volume":"171","author":"Berger","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0375","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1442-2042.2010.02479.x","article-title":"Is extended and saturation biopsy necessary?","volume":"17","author":"Scattoni","year":"2010","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0380","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/pcan.2008.34","article-title":"Sixteen gauge needles improve specimen quality but not cancer detection rate in transrectal ultrasound-guided 10-core prostate biopsies","volume":"11","author":"Inal","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0385","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2012.09.033","article-title":"Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care","volume":"63","author":"Ukimura","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0390","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.juro.2013.08.088","article-title":"The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance","volume":"191","author":"Ehdaie","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.urology.2013.02.068","article-title":"Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate?","volume":"82","author":"Liss","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0400","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2014.08.008","article-title":"Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis","volume":"193","author":"Cohen","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0405","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bju.13410","article-title":"Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study","volume":"118","author":"Bokhorst","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0410","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/JCM.02158-12","article-title":"Comparison of broth enhancement to direct plating for screening of rectal cultures for ciprofloxacin-resistant Escherichia coli","volume":"51","author":"Liss","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.urology.2016.12.011_bib0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.urology.2014.09.035","article-title":"Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study","volume":"85","author":"Dai","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0420","first-page":"73","article-title":"Reducing infectious complications following transrectal ultrasound-guided prostate biopsy: a systematic review","volume":"18","author":"Walker","year":"2016","journal-title":"Rev Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0425","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/2051415816651376","article-title":"Fluoroquinolone resistance colonization from initial to repeat prostate biopsy","volume":"9","author":"Liss","year":"2016","journal-title":"J Clin Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0430","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","article-title":"Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care","volume":"187","author":"Taylor","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0435","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0022-5347(01)69087-6","article-title":"The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique","volume":"167","author":"Davis","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0440","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s10350-008-9213-8","article-title":"Benefits of povidone-iodine solution in colorectal operations: science or legend","volume":"51","author":"Pattana-arun","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.urology.2016.12.011_bib0445","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11255-014-0713-2","article-title":"Reducing the risk of infection for transrectal prostate biopsy with povidone-iodine: a systematic review and meta-analysis","volume":"46","author":"Pu","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2016.12.011_bib0450","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00345-014-1291-8","article-title":"Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate","volume":"32","author":"Gyorfi","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0455","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s11255-016-1394-9","article-title":"Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications","volume":"48","author":"Ryu","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2016.12.011_bib0460","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.juro.2012.09.121","article-title":"A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy","volume":"189","author":"Abughosh","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0465","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/sur.2013.138","article-title":"Control of infective complications of transrectal prostate biopsy","volume":"15","author":"Park","year":"2014","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.urology.2016.12.011_bib0470","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-5347(05)67453-8","article-title":"Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy","volume":"164","author":"Lindert","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0475","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0090-4295(03)00470-9","article-title":"Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy","volume":"62","author":"Jeon","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.12.011_bib0480","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-5347(05)66082-X","article-title":"Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications?","volume":"166","author":"Carey","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0485","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5173\/ceju.2015.608","article-title":"Transrectal-ultrasound prostatic biopsy preparation: rectal enema vs. mechanical bowel preparation","volume":"68","author":"De Nunzio","year":"2015","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0490","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0495","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","article-title":"Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment","volume":"51","author":"Tumbarello","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0500","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2217\/fmb.12.100","article-title":"Detecting risk and predicting patient mortality in patients with extended-spectrum beta-lactamase-producing Enterobacteriaceae bloodstream infections","volume":"7","author":"Trecarichi","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.urology.2016.12.011_bib0505","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/AAC.02052-13","article-title":"Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries","volume":"58","author":"Rogers","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0510","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.urology.2016.12.011_bib0515","doi-asserted-by":"crossref","first-page":"15082","DOI":"10.1038\/srep15082","article-title":"Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae","volume":"5","author":"Zowawi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.urology.2016.12.011_bib0520","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/jac\/dkt266","article-title":"Rectal colonization with New Delhi metallo-beta-lactamase-1-producing Escherichia coli prior to transrectal ultrasound (TRUS)-guided prostate biopsy","volume":"68","author":"Williamson","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0525","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00009-11","article-title":"Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system","volume":"55","author":"Tumbarello","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0530","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1086\/669858","article-title":"Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum beta-lactamase-producing enterobacteriaceae on hospital admission","volume":"34","author":"Johnson","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.urology.2016.12.011_bib0535","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/cid\/ciw425","article-title":"A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum beta-lactamase-producing organism","volume":"63","author":"Goodman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0540","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000381271","article-title":"The value of rectal cultures in treatment of sepsis following post-transrectal ultrasound-guided prostate biopsy","volume":"95","author":"Gottesman","year":"2015","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2016.12.011_bib0545","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.urology.2016.12.011_bib0550","series-title":")","article-title":"Antimicrobial Resistance Surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2015"},{"key":"10.1016\/j.urology.2016.12.011_bib0555","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.urology.2016.12.011_bib0560","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","article-title":"Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices","volume":"70","author":"Pitout","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.urology.2016.12.011_bib0565","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrurol.2015.199","article-title":"The emerging threat of multidrug-resistant Gram-negative bacteria in urology","volume":"12","author":"Zowawi","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urology.2016.12.011_bib0570","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1179\/joc.2010.22.5.355","article-title":"Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection","volume":"22","author":"Senol","year":"2010","journal-title":"J Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0575","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/cid\/cit704","article-title":"Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?","volume":"58","author":"Gardiner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0580","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/jac\/dkv067","article-title":"Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis","volume":"70","author":"Rhodes","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0585","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/jac\/dks215","article-title":"Mecillinam\/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"67","author":"Lampri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0590","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1128\/AAC.00290-09","article-title":"Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli","volume":"53","author":"Adams-Haduch","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0595","first-page":"2418","article-title":"Comment on: the national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention","volume":"68","author":"Balakrishnan","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2016.12.011_bib0600","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/cid\/ciw378","article-title":"Ceftazidime-avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a phase 3 randomized trial program","volume":"63","author":"Wagenlehner","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urology.2016.12.011_bib0605","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(14)62220-0","article-title":"Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)","volume":"385","author":"Wagenlehner","year":"2015","journal-title":"Lancet"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516309530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516309530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T04:26:07Z","timestamp":1718943967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429516309530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":120,"alternative-id":["S0090429516309530"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2016.12.011","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2016.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}